- Home
- SNDX vs PDM Comparison
SNDX vs PDM Comparison
Compare SNDX & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- PDM
- Stock Information
- Founded
- SNDX 2005
- PDM 1997
- Country
- SNDX United States
- PDM United States
- Employees
- SNDX N/A
- PDM N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- PDM Building operators
- Sector
- SNDX Health Care
- PDM Real Estate
- Exchange
- SNDX Nasdaq
- PDM Nasdaq
- Market Cap
- SNDX 1.2B
- PDM 1.1B
- IPO Year
- SNDX 2016
- PDM N/A
- Fundamental
- Price
- SNDX $14.54
- PDM $8.59
- Analyst Decision
- SNDX Strong Buy
- PDM Buy
- Analyst Count
- SNDX 10
- PDM 3
- Target Price
- SNDX $36.20
- PDM $11.00
- AVG Volume (30 Days)
- SNDX 2.1M
- PDM 580.1K
- Earning Date
- SNDX 02-25-2025
- PDM 02-13-2025
- Dividend Yield
- SNDX N/A
- PDM 5.90%
- EPS Growth
- SNDX N/A
- PDM N/A
- EPS
- SNDX N/A
- PDM N/A
- Revenue
- SNDX $16,000,000.00
- PDM $572,424,000.00
- Revenue This Year
- SNDX N/A
- PDM N/A
- Revenue Next Year
- SNDX N/A
- PDM $0.18
- P/E Ratio
- SNDX N/A
- PDM N/A
- Revenue Growth
- SNDX N/A
- PDM N/A
- 52 Week Low
- SNDX $12.06
- PDM $5.93
- 52 Week High
- SNDX $25.34
- PDM $11.12
- Technical
- Relative Strength Index (RSI)
- SNDX 57.25
- PDM 42.84
- Support Level
- SNDX $13.61
- PDM $8.27
- Resistance Level
- SNDX $14.62
- PDM $8.95
- Average True Range (ATR)
- SNDX 0.62
- PDM 0.23
- MACD
- SNDX 0.15
- PDM 0.01
- Stochastic Oscillator
- SNDX 91.20
- PDM 35.51
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About PDM Piedmont Office Realty Trust Inc.
Piedmont Office Realty Trust Inc is a real estate investment trust engaged in the acquisition, development, and management of commercial real estate properties throughout the U.S. The company's real estate portfolio is mainly composed of office properties located in the majority of American metropolitan areas. Piedmont derives majority of its revenue in the form of rental income from tenants in mid- to long-term lease agreements. The vast majority of the company's revenue comes from the leasing of its assets in Washington D.C., New York City, Chicago, Atlanta, Minneapolis, Dallas, and Boston. Piedmont's large customers in terms of rental revenue are U.S. Government entities, business services companies, and financial institutions.